Glitazones and heart failure: critical appraisal for the clinician

Circulation. 2003 Mar 18;107(10):1350-4. doi: 10.1161/01.cir.0000054675.30348.9a.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Contraindications
  • Heart / drug effects
  • Heart / physiopathology
  • Heart Failure / chemically induced
  • Heart Failure / prevention & control*
  • Hemodynamics / drug effects
  • Humans
  • Hypertrophy, Left Ventricular / drug therapy
  • Hypoglycemic Agents / pharmacology
  • Hypoglycemic Agents / therapeutic use*
  • Metabolic Syndrome / drug therapy*
  • Middle Aged
  • Myocardial Contraction / drug effects
  • Myocardial Ischemia / drug therapy
  • Myocardial Reperfusion Injury / drug therapy
  • Myocardium / metabolism
  • Neurotransmitter Agents / metabolism
  • Thiazoles / pharmacology
  • Thiazoles / therapeutic use*
  • Vascular Resistance / drug effects

Substances

  • Hypoglycemic Agents
  • Neurotransmitter Agents
  • Thiazoles